menu ☰
menu ˟

VIDEO: Cemiplimab ‘a new standard’ for metastatic cutaneous squamous cell carcinoma

15 Jun 2019
CHICAGO — Cemiplimab demonstrated considerable antitumor activity among patients with metastatic cutaneous squamous cell carcinoma, according to results of the EMPOWER-CSCC-1 trial presented at ASCO Annual Meeting.Researchers concluded the trial re...

Click here to view the full article which appeared in Dermatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.